Mitsubishi Chemical Group Corporation (TYO:4188)
Japan
· Delayed Price · Currency is JPY | Market Cap | 1.09T |
| Revenue (ttm) | 4.41T |
| Net Income (ttm) | 45.02B |
| Shares Out | 1.39B |
| EPS (ttm) | 31.63 |
| PE Ratio | 24.73 |
| Forward PE | 8.06 |
| Dividend | 32.00 (4.09%) |
| Ex-Dividend Date | Sep 29, 2025 |
| Volume | 5,834,100 |
| Average Volume | 6,863,315 |
| Open | 780.70 |
| Previous Close | 782.10 |
| Day's Range | 780.70 - 788.50 |
| 52-Week Range | 594.10 - 957.80 |
| Beta | 0.36 |
| RSI | 61.46 |
| Earnings Date | Aug 1, 2025 |
About Mitsubishi Chemical Group
Mitsubishi Chemical Group Corporation provides performance products, chemicals, industrial gases, health care products, and other products in Japan and internationally. It operates in five segments: Specialty Materials, Industrial Gases, Health Care, MMA, and Basic Materials. The Specialty Materials segment offers performance polymers, soarnol, gohsenol, sustainable polymers, and engineering plastics; coating materials, additives, and fines; packaging, industrial and medical, acetyl, and polyester films; engineering shapes and solutions, carbon... [Read more]
Financial Performance
In 2024, Mitsubishi Chemical Group's revenue was 4.41 trillion, an increase of 0.46% compared to the previous year's 4.39 trillion. Earnings were 45.02 billion, a decrease of -62.36%.
Financial StatementsNews
Bain Capital to buy Mitsubishi Chemical’s pharma unit for $3.3B
Mitsubishi Chemical Looks to Sell Pharma Unit, Nikkei Reports
Japanese chemical producer Mitsubishi Chemical Group Corp. is looking to sell its pharmaceutical unit, Mitsubishi Tanabe Pharma Corp., Nikkei reported on Monday.